The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Bisoprolol and Fluvastatin for the Reduction of Perioperative Cardiac Mortality and Myocardial Infarction in Intermediate-Risk Patients Undergoing Noncardiovascular Surgery: A Randomized Controlled Trial (DECREASE-IV)
Abstract
In Brief Objective: This study evaluated the effectiveness and safety of beta-blockers and statins for the prevention of perioperative cardiovascular events in intermediate-risk patients undergoing noncardiovascular surgery. Summary Background Data: Beta-blockers and statins reduce perioperative cardiac events in high-risk patients undergoing vascular surgery by restoring the myocardial oxygen supply/demand balance and/or stabilizing coronary plaques. However, their effects in intermediate-risk patients remained ill-defined. Methods: In this randomized open-label 2 × 2 factorial design trial 1066 intermediate cardiac risk patients were assigned to bisoprolol, fluvastatin, combination treatment, or control therapy before surgery (median: 34 days). Intermediate risk was defined by an estimated risk of perioperative cardiac death and myocardial infarction (MI) of 1% to 6%, using clinical data and type of surgery. Starting dose of bisoprolol was 2.5 mg daily, titrated to a perioperative heart rate of 50 to 70 beats per minute. Fluvastatin was prescribed in a fixed dose of 80 mg. The primary end point was the composite of 30-day cardiac death and MI. This study is registered in the ISRCTN registry and has the ID number ISRCTN47637497. Results: Patients randomized to bisoprolol (N = 533) had a lower incidence of perioperative cardiac death and nonfatal MI than those randomized to bisoprolol-control (2.1% vs. 6.0% events; hazard ratios: 0.34; 95% confidence intervals: 0.17–0.67; P = 0.002). Patients randomized to fluvastatin experienced a lower incidence of the end point than those randomized to fluvastatin-control therapy (3.2% vs. 4.9% events; hazard ratios: 0.65; 95% confidence intervals: 0.35–1.10), but statistical significance was not reached (P = 0.17). Conclusion: Bisoprolol was associated with a significant reduction of 30-day cardiac death and nonfatal MI, while fluvastatin showed a trend for improved outcome. In this randomized trial including 1066 patients beta-blocker therapy was associated with a significant reduction (hazard ratios: 0.34, 95% confidence intervals: 0.17–0.67) in perioperative cardiovascular events in intermediate-risk patients undergoing noncardiovascular surgery. However, statin therapy was not associated with a significant reduction in perioperative cardiovascular events (hazard ratios: 0.65; 95% confidence intervals: 0.35–1.10).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multifactorial Index of Cardiac Risk in Noncardiac Surgical Procedures
Goldman, L., Caldera, D. L., Nussbaum, S. R., Southwick, F. S., Krogstad, D., Murray, B., Burke, D. S., O'Malley, T. A., Goroll, A. H., Caplan, C. H., et al. (1977) · New England Journal of Medicine · doi:10.1056/nejm197710202971601 · Cited by 2,751
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
Mangano, D. T., Layug, E. L., Wallace, A., & Tateo, I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612053352301 · Cited by 1,694
Universal Definition of Myocardial Infarction
Thygesen, K., Alpert, J. S., & White, H. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.011 · Cited by 1,618
Poldermans, D., Boersma, E., Bax, J. J., Thomson, I. R., van de Ven, L. L. M., Blankensteijn, J. D., Baars, H. F., Yo, T.-I., Trocino, G., Vigna, C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412402 · Cited by 1,496
Self-citationCrisby, M., Nordin-Fredriksson, G., Shah, P. K., Yano, J., Zhu, J., & Nilsson, J. (2001) · Circulation · doi:10.1161/01.cir.103.7.926 · Cited by 1,001
Beneficial Cardiovascular Pleiotropic Effects of Statins
Davignon, J. (2004) · Circulation · doi:10.1161/01.cir.0000131517.20177.5a · Cited by 955
Cannon, C. P., Battler, A., Brindis, R. G., Cox, J. L., Ellis, S. G., Every, N. R., Flaherty, J. T., Harrington, R. A., Krumholz, H. M., Simoons, M. L., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01702-8 · Cited by 671
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
(1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361426 · Cited by 661
Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial
Durazzo, A. E. S., Machado, F. S., Ikeoka, D. T., De Bernoche, C., Monachini, M. C., Puech-Leão, P., & Caramelli, B. (2004) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.01.004 · Cited by 595
Fleisher, L. A., Beckman, J. A., Brown, K. A., Calkins, H., Chaikof, E., Fleischmann, K. E., Freeman, W. K., Froehlich, J. B., Kasper, E. K., Kersten, J. R., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.001 · Cited by 537
UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION
Thygesen, K., Alpert, J., & White, H. (2008) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2008-4-5-91-105 · Cited by 525
Poldermans, D., Bax, J. J., Kertai, M. D., Krenning, B., Westerhout, C. M., Schinkel, A. F. L., Thomson, I. R., Lansberg, P. J., Fleisher, L. A., Klein, J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066286.15621.98 · Cited by 484
Self-citationLipid-Lowering Therapy and In-Hospital Mortality Following Major Noncardiac Surgery
Lindenauer, P. K. (2004) · JAMA · doi:10.1001/jama.291.17.2092 · Cited by 474
Boersma, E., Kertai, M. D., Schouten, O., Bax, J. J., Noordzij, P., Steyerberg, E. W., Schinkel, A. F. L., van Santen, M., Simoons, M. L., Thomson, I. R., et al. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.01.064 · Cited by 380
Self-citationYang, H., Raymer, K., Butler, R., Parlow, J., & Roberts, R. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.07.024 · Cited by 362
Juul, A. B., Wetterslev, J., Gluud, C., Kofoed-Enevoldsen, A., Jensen, G., Callesen, T., N⊘rgaard, P., Fruergaard, K., Bestle, M., Vedelsdal, R., et al. (2006) · BMJ · doi:10.1136/bmj.332.7556.1482 · Cited by 359
Fleisher, L. A., Beckman, J. A., Brown, K. A., Calkins, H., Chaikof, E., Fleischmann, K. E., Freeman, W. K., Froehlich, J. B., Kasper, E. K., Kersten, J. R., et al. (2008) · Anesthesia & Analgesia · doi:10.1213/01/ane.0000309024.28586.70 · Cited by 350
Powell, J. T. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.01.048 · Cited by 336
β-Blockers and Reduction of Cardiac Events in Noncardiac Surgery: Scientific Review
Auerbach, A. D., & Goldman, L. (2002) · JAMA · doi:10.1001/jama.287.11.1435 · Cited by 333
Raby, K. E., Brull, S. J., Timimi, F., Akhtar, S., Rosenbaum, S., Naimi, C., & Whittemore, A. D. (1999) · Anesthesia & Analgesia · doi:10.1097/00000539-199903000-00002 · Cited by 304
The role of plaque rupture and thrombosis in coronary artery disease
Zaman, A. G., Helft, G., Worthley, S. G., & Badimon, J. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00479-7 · Cited by 280
Katsimaglis, G., Danias, P. G., Danias, P. G., O'Neil-Callahan, K., Ryan, J., Mosby, C., Danias, P. G., Katsimaglis, G., Ioannidis, J. P. A., Ioannidis, J. P. A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.048 · Cited by 276
Prabhu, S. D., Chandrasekar, B., Murray, D. R., & Freeman, G. L. (2000) · Circulation · doi:10.1161/01.cir.101.17.2103 · Cited by 265
Poldermans, D., Bax, J. J., Schouten, O., Neskovic, A. N., Paelinck, B., Rocci, G., van Dortmont, L., Durazzo, A. E. S., van de Ven, L. L. M., van Sambeek, M. R. H. M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.059 · Cited by 264
Self-citationOhtsuka, T., Hamada, M., Hiasa, G., Sasaki, O., Suzuki, M., Hara, Y., Shigematsu, Y., & Hiwada, K. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01121-9 · Cited by 253
Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Buller, E., Creager, M. A., Ettinger, S. M., Faxon, D. P., Jacobs, A. K., Adams, C. D., et al. (2007) · Cited by 248
Buksińska−Lisik, M. (2008) · PubMed · Cited by 204
Kertai, M. D., Boersma, E., Westerhout, C. M., Klein, J., van Urk, H., Bax, J. J., Roelandt, J. R. T. C., & Poldermans, D. (2004) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2004.07.008 · Cited by 194
Self-citationKertai, M. D., Boersma, E., Westerhout, C. M., Klein, J., van Urk, H., Bax, J. J., Roelandt, J. R. T. C., & Poldermans, D. (2011) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2011.06.016 · Cited by 184
Self-citationHoeks, S. E., Scholte op Reimer, W. J. M., van Urk, H., Jörning, P. J. G., Boersma, E., Simoons, M. L., Bax, J. J., & Poldermans, D. (2007) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2006.06.019 · Cited by 171
Self-citationApproaches to the Prevention of Perioperative Myocardial Ischemia
Warltier, D. C., Pagel, P. S., & Kersten, J. R. (2000) · Anesthesiology · doi:10.1097/00000542-200001000-00038 · Cited by 155
Lawrie, S. M., & McAllister-Williams, R. H. (2015) · CRC Press eBooks · doi:10.1201/b18821-20 · Cited by 143
Safety of perioperative statin use in high-risk patients undergoing major vascular surgery
Schouten, O., Kertai, M. D., Bax, J. J., Durazzo, A., Biagini, E., Boersma, E. H., van Waning, V. H., Lameris, T. W., van Sambeek, M. R. H. M., & Poldermans, D. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.10.046 · Cited by 134
Self-citationSipahi, İ., Tuzcu, E. M., Wolski, K. E., Nicholls, S. J., Schoenhagen, P., Hu, B., Balog, C., Shishehbor, M. H., Magyar, W. A., Crowe, T. D., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-1-200707030-00003 · Cited by 112
Jenkins, N. P., Keevil, B. G., Hutchinson, I. V., & Brooks, N. H. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01115-9 · Cited by 106
Peto, R. (1978) · Nature · doi:10.1038/272015a0 · Cited by 106
Alteration of cellular ribonucleases associated with murine oncogenic virus infection.
Wp, D., Lm, F., Sidle, D., et al. (1978) · PubMed · Cited by 94
Schouten, O., Poldermans, D., Visser, L. E., Kertai, M. D., Klein, J., van Urk, H., Simoons, M. L., van de Ven, L. L. M., Vermeulen, M., Bax, J. J., et al. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.05.046 · Cited by 88
Self-citation
Cited by
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
Fleisher, L. A., Fleischmann, K. E., Auerbach, A. D., Barnason, S. A., Beckman, J. A., Bozkurt, B., Davila-Roman, V. G., Gerhard-Herman, M. D., Holly, T. A., Kane, G. C., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000106 · Cited by 1,820
Fleisher, L. A., Fleischmann, K. E., Auerbach, A. D., Barnason, S. A., Beckman, J. A., Bozkurt, B., Davila-Roman, V. G., Gerhard-Herman, M. D., Holly, T. A., Kane, G. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.07.944 · Cited by 1,320
Fleisher, L. A., Fleischmann, K. E., Auerbach, A. D., Barnason, S. A., Beckman, J. A., Bozkurt, B., Davila-Roman, V. G., Gerhard-Herman, M. D., Holly, T. A., Kane, G. C., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000105 · Cited by 800
Authors/Task Force Members, Poldermans, D., Bax, J. J., Boersma, E., De Hert, S., Eeckhout, E., Fowkes, G., Gorenek, B., Hennerici, M. G., Iung, B., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp337 · Cited by 738
Self-citation
Metadata
- Authors
- Dunkelgrun, M., Boersma, E., Schouten, O., Koopman-van Gemert, A. W. M. M., van Poorten, F., Bax, J. J., Thomson, I. R., & Poldermans, D.
- Venue
- Annals of Surgery
- Published
- 2009-06
- Volume
- 249
- Issue
- 6
- Pages
- 921-926
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2005040494
- Cited by
- 310
- References
- 39
- FWCI
- 26.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.